Innovations within the cornea realm are flourishing. In this article, I review emerging technologies to treat corneal diseases.
James Funderburgh, PhD, at the University of Pittsburgh discovered stem cells in the corneal stroma in an effort to use these cells to reduce corneal scarring. In early animal studies and registered human clinical trials in India, Funderburgh and colleagues demonstrated that human corneal stromal stem cells (CSSCs) can regenerate in vitro, and when introduced into the patient’s corneal stroma, these healthy CSSCs can prevent trauma-induced corneal scarring,